Enanta Pharmaceuticals Inc XNAS: ENTA

Enanta Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Enanta Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Enanta Pharmaceuticals Inc
Rating: 1.206722125
Author: Trendlyne DVM scores

Weak Stock

Download real time

5.10 0.17 (3.45%)

70.42% Fall from 52W High

183.5K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

23.3 / 100

Technically Bearish

28.8 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

15

1Yr Price target upside is 197%

7 analysts

Enanta Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Enanta Pharmaceuticals Inc FAQ

How is Enanta Pharmaceuticals Inc today?

Enanta Pharmaceuticals Inc today is trading in the green, and is up by 3.45% at 5.10.

How has Enanta Pharmaceuticals Inc performed historically?

Enanta Pharmaceuticals Inc is currently trading up 3.45% on an intraday basis. In the past week the stock rose 13.33%. stock has been up 5.15% in the past quarter and fell -66.80% in the past year. You can view this in the overview section.